Final Call for Abstracts – Deadline Today!⏳ Don't miss your chance to be part of the #InSiGHT2026 Biennial Meeting in #Singapore! 🌏 🗓️ Submission Deadline: 30 September 2025 ⏰ Time: Midnight (Singapore Time) / 6pm CET Submit your abstract now! insight2026.org/abstract-sub... #Genetics #GIcancer

🚨 Final Call: Abstract submissions for #InSiGHT2026 close TOMORROW – Sept 30! Join the global conversation on hereditary GI tumours. Submit now 👉 insight2026.org Let your research drive progress. #MedicalResearch #Genetics #GIcancer #AbstractSubmission

Our results support universal and paired somatic and germline multi-gene panels for all EOCRC patients, regardless of MMR status or family history onlinelibrary.wiley.com/doi/10.1002/...

Genetic testing appears to have limited utility in SPS patients and may primarily identify those with an incidental diagnosis of Lynch syndrome pubmed.ncbi.nlm.nih.gov/41002021/

Cancer is an evolutionary disease, but does knowing a cancer’s evolutionary past help predict its future? Out today in @nature, we learnt the evolution of 2000 lymphoid cancers and found it was highly correlated with clinical outcomes! (1/7) rdcu.be/eFrrc

Lineage tracking using methylation states from longitudinal bulk sampling. Sounds 🆒 and given recent work by @trevorgraham.bsky.social and colleagues, looks real. Wondering about other applications like 🦠🧫 👉🏻News and views: www.nature.com/articles/d41... 👉🏻Paper www.nature.com/articles/s41...

🚨 It’s here! The Scientific Program for InSiGHT 2026 (4–7 March, Singapore 🇸🇬) is now live! 🔗 Check out the full program: insight2026.org/scientific-programme 🧬 Abstracts due 30 Sept – submit yours: insight2026.org/abstract-submission-guidelines #InSiGHT2026 #HereditaryCancer #GICancerResearch

🚀 Exciting news! We’re launching Young-Insight for InSiGHT members under 40. Join our first meeting to share ideas & shape the future of our community. Email [email protected] with subject “Young Insight” to get involved! 🌍✨ #InSiGHT

The registries’ combined experiences underscore the critical need for integrated, culturally sensitive strategies combining genetic testing, enhanced surveillance, and family-based management to improve outcomes #Polyposis #LynchSyndrome link.springer.com/article/10.1...

📢 Join us in Singapore for the InSiGHT Biennial Meeting, 4–7 March 2026! 🔹 Abstract Deadline: 20 Sept 2025 🔹 Early Bird: 10 Jan 2026 Link ➡️ insight2026.org Let’s advance hereditary GI cancer research together! #InSiGHT2026 #MedicalResearch #GItumours

Come and work with us! We are seeking a Regional #LynchSyndrome Nursing Lead band 8 for 12 months to provide teaching and training across North London #Genomics apps.trac.jobs/job-advert/7...

Please follow @insight-org.bsky.social on BlueSky and join us for insight2026.org in Singapore, abstract submission now live!

Please follow @insight-org.bsky.social on BlueSky and join us for insight2026.org in Singapore, abstract submission now live!

👋 Welcome to InSiGHT on BlueSky! We are a global community of researchers, clinicians, and scientists dedicated to advancing the understanding, diagnosis, and management of hereditary GI cancers. Follow us for updates on scientific advances, clinical guidelines, and upcoming events. #InSiGHT

Abstract submission is now open for #Insight2026 ! Deadline 7th September #LynchSyndrome #Polyposis #EOCRC @soniakupfer.bsky.social @swatipatelmd.bsky.social @cgaigc.com @stmarksgenomics.bsky.social @plsdatabase.bsky.social insight2026.org

Mainstreaming clinicians in colorectal and Gynae teams… think about this study!

Join us 19-21 November for a bigger and better St Mark's Frontiers in Colorectal Disease Meeting, in a beautiful venue in King's Cross London! Extremely good value, with hybrid options @stmarkshospital.bsky.social sayso.health/events/front...

Join us 19-21 November for a bigger and better St Mark's Frontiers in Colorectal Disease Meeting, in a beautiful venue in King's Cross London! Extremely good value, with hybrid options @stmarkshospital.bsky.social sayso.health/events/front...

Missed opportunities: Germline testing following tumor sequencing pubmed.ncbi.nlm.nih.gov/40554180/

Great to meet up with Pam from Lynch Syndrome UK at BSG Live 2025 in Glasgow today! @thepoodoctor.bsky.social @lynchsyndromeuk.bsky.social @stmarksgenomics.bsky.social

On behalf of InSiGHT, we are delighted to welcome you to the #InSiGHT2026 meeting in Singapore, taking place from 4 – 7 March 2026 #LynchSyndrome #Polyposis @cgaigc.com @stmarksgenomics.bsky.social insight2026.org

On behalf of InSiGHT, we are delighted to welcome you to the #InSiGHT2026 meeting in Singapore, taking place from 4 – 7 March 2026 #LynchSyndrome #Polyposis @cgaigc.com @stmarksgenomics.bsky.social insight2026.org

Lovely new paper from @leedham-simon.bsky.social dissecting epithelium-microenvironment crosstalk through BMP & wnt signalling in the intestine. Inhibition of BMP antagonist GREM1 may forestall polyp formation in Hereditary Mixed Polyposis Syndrome (HMPS). www.nature.com/articles/s41...

In Our Scope of Practice: Genetic Risk Assessment and Testing for GI Cancers and Polyposis in Gastroenterology - @amergastroassn.bsky.social @soniakupfer.bsky.social www.gastrojournal.org/article/S001...

Are you an #endoscopist? Interested in assessing & managing advanced #colonic #polyps? Can we improve our #training in this? @stmarkshospital.bsky.social We are keen to hear your views. Please complete this short survey @esge-news.bsky.social docs.google.com/forms/d/e/1F...

Led by our 2024 president, Bryson Katona, MD, PhD, our Executive Council developed a 3-year strategic plan to guide our society's future We’re proud to share this as we mark our 30th anniversary. Explore the plan 👉https://link.springer.com/article/10.1007/s10689-025-00473-9 #HereditaryGICancer

If you are a from a #colorectalcancer #MDT and offering mainstream #genetic testing to your own patients then please consider joining Detect2 which may half your workload! We’re delighted to have recruited our first 3 patients… get in touch or click below for more www.detect-2.co.uk

Attitudes towards faecal immunochemical testing (FIT) for risk-stratified colonoscopy in people with #Lynchsyndrome #FIT4Lynch @bmj.com bmjopengastro.bmj.com/content/12/1...

The BSL during Finland was sensational #Eurovision

Fantastic meeting about Lynch syndrome and hereditary CRC for MDTs, thanks to @britsocgastro.bsky.social @kevinmonahan.bsky.social and others

Fabulous day today at our @britsocgastro.bsky.social organised #LynchSyndrome event at #RCPLondon sold out, fabulous talks, interactive sessions and audience of clinicians who want to do their best for people with Lynch syndrome #BCSP @nhsmillion.bsky.social @rcphysicians.bsky.social

We are very excited about our @britsocgastro.bsky.social #LynchSyndrome event @rcphysicians.bsky.social next Wednesday… sold out but let me know if you want a place

Primary care: the ‘linchpin’ in Lynch syndrome @bjgp.bsky.social bjgp.org/content/75/7...

Please join our incredible team as an Advanced Nurse Practitioner in Inherited Cancer Syndromes - closing date this Monday 5th May! Provide lifelong care to our very special patient group #LynchSyndrome #FAP #Genomics #polyposis @stmarkshospital.bsky.social lnwh.nhs.uk/jobs/

One hundred years of the St Mark’s hospital polyposis registry @stmarksgenomics.bsky.social @lnwh.bsky.social link.springer.com/article/10.1...

Promising early safety and immunogenicity data from the Nous-209 Lynch Syndrome vaccine presented at AACR this month aacrjournals.org/cancerres/ar...

Could or is crumbling? @nature.com www.nature.com/articles/d41...

On Full-Body MRI “The odds that you’re going to be hurt are higher than the odds you’re going to be helped” time.com/7275819/shou...

This is Ripley. He was nervous about taking the stairs. May have panicked a bit. 12/10

Guidelines for Familial Adenomatous Polyposis (FAP): challenges in defining clinical management for a rare disease link.springer.com/article/10.1...

We had our third meeting this week of the UK Early onset colorectal cancer research consortium this week, designed to develop research projects in #EOCRC, supported by amazing patients and @bowelcanceruk.bsky.social #BSG @stmarksgenomics.bsky.social @imperialcollegeldn.bsky.social

This is brilliant - super clear and a must-have resource for who (and who not) to test in the clinic. Highly recommend!

The National Genomics Education Programme have launched #GeNotes collection specifically for #Genomics cases in your practice @britsocgastro.bsky.social www.bsg.org.uk/news/new-nat...

This event is sold out but there is a waiting list… see the BSG email in the link

Addressing uncertainty in hereditary colorectal cancer: the role of a regional expert multidisciplinary team meeting link.springer.com/article/10.1...

Closing date tomorrow! Join our incredible team - We are a really supportive group, lots of opportunities for learning and such a fantastic role providing lifelong care to our very special patient group #LynchSyndrome #FAP #Genomics #PolyposisSyndromes #Nursing www.jobs.nhs.uk/candidate/jo...

The number of ways to activate the immune system attack vs cancer keeps increasing. Here, using bacteria to amp up the response to wild tumor, the mechanism via a surge of interleukin-10 is elucidated www.cell.com/cell/fulltex... @cellpress.bsky.social open-access

It’s an honour to launch Gastroenterology and Hepatology Genomics Resources’GeNotes’ published today by the Genomics Education Programme, designed for clinicians who are increasingly implementing genomics in their routine clinical practice www.genomicseducation.hee.nhs.uk/news/new-in-...

'Did you even say thank you?'